Sen. Burr Worries Rising User Fees Helping US FDA Evade Congressional Oversight
Executive Summary
Burr wants more FDA accountability in the new user fee agreements and questions whether they benefit patients. Generic approval modifications get attention at hearing.
You may also be interested in...
User Fee Carryover Funds Again Decrease Potential Furloughs In US FDA Shutdown Plan
More than 80% of FDA employees would continue working during a government shutdown, which appears unlikely as congressional negotiators announce a ‘framework’ agreement.
US FDA Shutdown Plan Decreases Potential Furloughs Again, Thanks To User Fee Carryover Funds
More than 80% of FDA employees would continue working during a government shutdown, which appears unlikely as congressional negotiators announce a ‘framework’ agreement.
US FDA Exploring Furlough Possibility If User Fee Bill Not Enacted In Time
Furloughs would allow affected FDA staff to remain employed, while a layoffs would require affected workers to be rehired.